Addex Therapeutics Ltd (ADXN) DCF Valuation

Addex Therapeutics Ltd (ADXN) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

Addex Therapeutics Ltd (ADXN) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Discover the true potential of Addex Therapeutics Ltd (ADXN) with our advanced DCF Calculator! Adjust crucial assumptions, explore various scenarios, and evaluate how different changes affect Addex Therapeutics Ltd (ADXN) valuation – all within a user-friendly Excel template.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 3.1 4.0 3.2 1.6 1.8 1.7 1.6 1.5 1.4 1.3
Revenue Growth, % 0 30.77 -19.28 -51.22 13.39 -6.59 -6.59 -6.59 -6.59 -6.59
EBITDA -15.9 -13.8 -16.6 -22.4 -11.3 -1.7 -1.6 -1.5 -1.4 -1.3
EBITDA, % -518.25 -343.51 -512.34 -1422.11 -634.16 -100 -100 -100 -100 -100
Depreciation .4 .4 .4 .4 .3 .3 .2 .2 .2 .2
Depreciation, % 12.08 10.48 11.92 22.72 18.97 15.23 15.23 15.23 15.23 15.23
EBIT -16.2 -14.2 -16.9 -22.8 -11.7 -1.7 -1.6 -1.5 -1.4 -1.3
EBIT, % -530.33 -353.99 -524.26 -1444.83 -653.13 -100 -100 -100 -100 -100
Total Cash 35.0 20.8 22.7 7.7 4.3 1.7 1.6 1.5 1.4 1.3
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .1 .1 .4 .7 .2
Account Receivables, % 4.27 1.89 11.12 42.06 9.38
Inventories .0 .2 .0 -966.2 .0 -.3 -.3 -.3 -.3 -.2
Inventories, % -0.50557 4.51 0.000034289931 -61275.4 0 -19.2 -19.2 -19.2 -19.2 -19.2
Accounts Payable 2.5 1.1 2.0 1.4 1.1 1.1 1.0 .9 .9 .8
Accounts Payable, % 80.21 27.22 61.29 89.74 61.03 63.9 63.9 63.9 63.9 63.9
Capital Expenditure .0 -.1 .0 .0 .0 .0 .0 .0 .0 .0
Capital Expenditure, % -1.03 -1.64 -1.08 -0.04084537 -0.42419 -0.84429 -0.84429 -0.84429 -0.84429 -0.84429
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -16.2 -14.2 -16.9 -22.8 -11.7 -1.7 -1.6 -1.5 -1.4 -1.3
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -13.6 -15.3 -15.8 942.9 -977.4 -1.2 -1.4 -1.3 -1.2 -1.2
WACC, % 13.29 13.29 13.29 13.29 13.29 13.29 13.29 13.29 13.29 13.29
PV UFCF
SUM PV UFCF -4.4
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) -1
Terminal Value -10
Present Terminal Value -6
Enterprise Value -10
Net Debt -4
Equity Value -6
Diluted Shares Outstanding, MM 74
Equity Value Per Share -0.08

What You Will Get

  • Editable Forecast Inputs: Easily modify assumptions (growth %, margins, WACC) to create various scenarios for Addex Therapeutics Ltd (ADXN).
  • Real-World Data: Addex Therapeutics’ financial data pre-filled to facilitate your analysis.
  • Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value for you.
  • Customizable and Professional: A refined Excel model that adjusts to your valuation requirements.
  • Built for Analysts and Investors: Perfect for evaluating projections, validating strategies, and enhancing efficiency.

Key Features

  • Comprehensive Data: Addex Therapeutics Ltd's historical financial statements and pre-filled forecasts.
  • Customizable Variables: Adjust WACC, tax rates, revenue growth, and EBITDA margins to suit your analysis.
  • Real-Time Insights: Instantly view the intrinsic value of Addex Therapeutics Ltd (ADXN) as it recalculates.
  • Intuitive Visualizations: Dashboard charts present valuation results and essential metrics clearly.
  • Designed for Precision: A reliable tool tailored for analysts, investors, and finance professionals.

How It Works

  1. Step 1: Download the Excel file.
  2. Step 2: Review pre-entered Addex Therapeutics data (historical and projected).
  3. Step 3: Adjust key assumptions (yellow cells) based on your analysis.
  4. Step 4: View automatic recalculations for Addex Therapeutics' intrinsic value.
  5. Step 5: Use the outputs for investment decisions or reporting.

Why Choose This Calculator for Addex Therapeutics Ltd (ADXN)?

  • Accurate Data: Utilize real Addex Therapeutics financials for trustworthy valuation outcomes.
  • Customizable: Tailor essential parameters such as growth rates, WACC, and tax rates to align with your forecasts.
  • Time-Saving: Pre-built calculations streamline the process, eliminating the need to start from the ground up.
  • Professional-Grade Tool: Crafted for investors, analysts, and consultants in the biotech sector.
  • User-Friendly: Simple layout and guided instructions ensure accessibility for all users.

Who Should Use This Product?

  • Pharmaceutical Students: Understand drug development processes and apply them using real market data.
  • Researchers: Integrate advanced models into studies or academic papers related to therapeutics.
  • Investors: Evaluate your investment strategies and assess valuation scenarios for Addex Therapeutics Ltd (ADXN).
  • Market Analysts: Enhance your analysis with a customizable financial model tailored for biotech companies.
  • Healthcare Entrepreneurs: Learn how large biotech firms like Addex Therapeutics Ltd (ADXN) are evaluated in the market.

What the Template Contains

  • Comprehensive DCF Model: Editable template with detailed valuation calculations tailored for Addex Therapeutics Ltd (ADXN).
  • Real-World Data: Addex Therapeutics' historical and projected financials preloaded for analysis.
  • Customizable Parameters: Adjust WACC, growth rates, and tax assumptions to test various scenarios.
  • Financial Statements: Complete annual and quarterly breakdowns for deeper insights into Addex Therapeutics Ltd (ADXN).
  • Key Ratios: Built-in analysis for profitability, efficiency, and leverage specific to Addex Therapeutics Ltd (ADXN).
  • Dashboard with Visual Outputs: Charts and tables for clear, actionable results relevant to Addex Therapeutics Ltd (ADXN).

Es wurden keine passenden Produkte gefunden.